[1]CurrentPatentAssignee:CAPELLATHERAPEUTICS-WO2017/53537,2017,A1
2246605-51-4 | 1-[2-chloro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(propan-2-yl)urea | AA00UIWQ | MFCD32661433
1183463-28-6 | 1-amino-N-(3,4-dimethoxyphenyl)cyclopentane-1-carboxamide | AA019TM0 | MFCD12734590
14201-93-5 | 2-(3,5,7-Trimethyladamantan-1-yl)acetic acid | AA019X8H | MFCD00167804
1235441-00-5 | 2-[3-(chloromethyl)phenoxy]acetamide | AA01A7O8 | MFCD14705786
1258650-02-0 | N-(3-acetylphenyl)-N-methanesulfonylmethanesulfonamide | AA01AB0L | MFCD17977051
1311313-98-0 | 2,2,2-trifluoroethyl N-(3-chloro-1-benzothiophen-2-yl)carbamate | AA01AIHY | MFCD18917302
1532190-93-4 | 3-(1H-1,2,3-triazol-1-yl)benzene-1-sulfonyl chloride | AA01B7LD | MFCD24105305
1196145-01-3 | Benzyl 3-amino-4-oxopiperidine-1-carboxylate hydrochloride | AA000P6Z | MFCD12756125
201595-71-3 | Propanoic-13C3 acid, 2-hydroxy-, monosodium salt, (2S)- (9CI) | AA002DFP | MFCD00084069
79707-11-2 | 2-Methylimidazo[1,2-a]pyridin-8-ol | AA005IIY | MFCD05863338